BJ
STML

BlackRock Japan’s Stemline Therapeutics, Inc. STML Stock Holding History

BlackRock Japan’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,336
Closed -$11K – 1531
2016
Q1 		$11K Buy
2,336
+237
+11% +$1.16K ﹤0.01% 1284
2015
Q4 		$13K Buy
+2,099
New +$17K ﹤0.01% 1239
2015
Q3 		– Sell
-1,511
Closed -$18K – 1397
2015
Q2 		$18K Buy
+1,511
New +$21K ﹤0.01% 1218
2014
Q2 		– Sell
-289
Closed -$6K – 1446
2014
Q1 		$6K Buy
289
+232
+407% +$5.63K ﹤0.01% 1367
2013
Q4 		$1K Sell
57
-511
-90% -$13.6K ﹤0.01% 1333
2013
Q3 		$26K Sell
568
-913
-62% -$29.8K ﹤0.01% 1205
2013
Q2 		$35K Buy
+1,481
New +$23.6K ﹤0.01% 1152

Other funds holding STML

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Japan's STML Position: Q2 2016 in Review

BlackRock Japan sold out of Stemline Therapeutics, Inc. (STML) in Q2 2016, closing a stake of 2,336 shares — an estimated $11K sold.

BlackRock Japan first reported a position in STML in Q2 2013 and held it in 7 quarters. The position peaked at $35K in Q2 2013. 61 funds tracked by Wall St. Rank hold STML as of Q2 2016.

  • BlackRock Japan reported no remaining Stemline Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • BlackRock Japan sold 2,336 Stemline Therapeutics, Inc. shares in Q2 2016, an estimated $11K.
  • BlackRock Japan first reported a position in Stemline Therapeutics, Inc. in Q2 2013 and held it in 7 quarters.
  • BlackRock Japan's Stemline Therapeutics, Inc. position peaked at $35K in Q2 2013.
  • 61 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2016.

Based on BlackRock Japan's 13F filing for Q2 2016, filed 10 Aug 2016.